Literature DB >> 19652202

Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6.

Kimberly D Dyer1, Caroline M Percopo, Elizabeth R Fischer, Stanislaw J Gabryszewski, Helene F Rosenberg.   

Abstract

Eosinophils are recruited to the lung in response to infection with pneumovirus pathogens and have been associated with both the pathophysiologic sequelae of infection and, more recently, with accelerated virus clearance. Here, we demonstrate that the pneumovirus pathogens, respiratory syncytial virus (RSV) and pneumonia virus of mice (PVM), can infect human and mouse eosinophils, respectively, and that virus infection of eosinophils elicits the release of disease-related proinflammatory mediators from eosinophils. RSV replication in human eosinophils results in the release of infectious virions and in the release of the proinflammatory mediator, interleukin-6 (IL-6). PVM replication in cultured bone marrow eosinophils (bmEos) likewise results in release of infectious virions and the proinflammatory mediators IL-6, IP-10, CCL2, and CCL3. In contrast to the findings reported in lung tissue of RSV-challenged mice, PVM replication is accelerated in MyD88 gene-deleted bmEos, whereas release of cytokines is diminished. Interestingly, exogenous IL-6 suppresses virus replication in MyD88 gene-deleted bmEos, suggesting a role for a MyD88-dependent cytokine-mediated feedback circuit in modulating this response. Taken together, our findings suggest that eosinophils are targets of virus infection and may have varied and complex contributions to the pathogenesis and resolution of pneumovirus disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652202      PMCID: PMC2756124          DOI: 10.1182/blood-2009-01-199497

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

Review 1.  Eosinophil cytokines.

Authors:  P Lacy; R Moqbel
Journal:  Chem Immunol       Date:  2000

2.  Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.

Authors:  S Aung; J A Rutigliano; B S Graham
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 3.  The trials and tribulations of IL-5, eosinophils, and allergic asthma.

Authors:  P M O'Byrne; M D Inman; K Parameswaran
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

4.  Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.

Authors:  H A Haeberle; W A Kuziel; H J Dieterich; A Casola; Z Gatalica; R P Garofalo
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.

Authors:  L K Hallak; D Spillmann; P L Collins; M E Peeples
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays.

Authors:  Y Zhang; B A Luxon; A Casola; R P Garofalo; M Jamaluddin; A R Brasier
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Pulmonary eosinophilia and production of MIP-1alpha are prominent responses to infection with pneumonia virus of mice.

Authors:  J B Domachowske; C A Bonville; K D Dyer; A J Easton; H F Rosenberg
Journal:  Cell Immunol       Date:  2000-03-15       Impact factor: 4.868

8.  Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice.

Authors:  Caroline M Percopo; Zhijun Qiu; Simon Phipps; Paul S Foster; Joseph B Domachowske; Helene F Rosenberg
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

9.  Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology.

Authors:  G Walzl; S Matthews; S Kendall; J C Gutierrez-Ramos; A J Coyle; P J Openshaw; T Hussell
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

10.  Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects.

Authors:  D J Adamko; B L Yost; G J Gleich; A D Fryer; D B Jacoby
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

View more
  45 in total

1.  Respiratory syncytial virus infection in human bone marrow stromal cells.

Authors:  Fariba Rezaee; Laura F Gibson; Debbie Piktel; Sreekumar Othumpangat; Giovanni Piedimonte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-22       Impact factor: 6.914

Review 2.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

3.  High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART.

Authors:  L A Ramirez; T A Arango; E Thompson; M Naji; P Tebas; J D Boyer
Journal:  J Leukoc Biol       Date:  2014-08-25       Impact factor: 4.962

Review 4.  Chronic Pancreatitis and the Development of Pancreatic Cancer.

Authors:  Hemanth K Kandikattu; Sathisha U Venkateshaiah; Anil Mishra
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2020       Impact factor: 2.895

5.  A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies.

Authors:  Bénédicte Machiels; Laurent Gillet; Mickaël Dourcy; Céline Maquet; Lorène Dams; Gautier Gilliaux; Justine Javaux; Daniel Desmecht; Matthias Mack; Benjamin G Dewals
Journal:  Mucosal Immunol       Date:  2020-05-18       Impact factor: 7.313

Review 6.  Pattern-recognition receptors in human eosinophils.

Authors:  Anne Månsson Kvarnhammar; Lars Olaf Cardell
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

7.  The emerging role of CXCL10 in cancer (Review).

Authors:  Mingli Liu; Shanchun Guo; Jonathan K Stiles
Journal:  Oncol Lett       Date:  2011-05-09       Impact factor: 2.967

8.  Activated mouse eosinophils protect against lethal respiratory virus infection.

Authors:  Caroline M Percopo; Kimberly D Dyer; Sergei I Ochkur; Janice L Luo; Elizabeth R Fischer; James J Lee; Nancy A Lee; Joseph B Domachowske; Helene F Rosenberg
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113

9.  Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Authors:  Peter L Collins; Rachel Fearns; Barney S Graham
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection.

Authors:  Jonathan M Ciencewicki; Xuting Wang; Jacqui Marzec; M Elina Serra; Douglas A Bell; Fernando P Polack; Steven R Kleeberger
Journal:  FASEB J       Date:  2014-01-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.